Yet another study has found that cannabinoids may treat or at least greatly benefit those with post traumatic stress disorder (and may prevent it if administered shortly after a traumatic event). The new study was published in the journal Behavioural Pharmacology, and published online by the National Institute of Health.
“There is substantial evidence from studies in humans and animal models for a role of the endocannabinoid system in the control of emotional states”, says the study’s abstract. It states that preliminary studies in humans “suggest that treatment with cannabinoids may decrease PTSD symptoms including sleep quality, frequency of nightmares, and hyperarousal.”
Moreover, “cannabinoids administered shortly after exposure to a traumatic event were found to prevent the development of PTSD-like phenotype. ”
For the current study, researchers reviewed “the existing literature on the use of cannabinoids for treating and preventing PTSD in humans and animal models”, and found that although “There is a need for large-scale clinical trials examining the potential decrease in PTSD symptomatology with the use of cannabis”, “Nevertheless, the end result of the current clinical and preclinical data is that cannabinoid agents may offer therapeutic benefits for PTSD.”
The full study can be found by clicking here.